Other

Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five

Veradermics Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 283.9% to $100.73M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Provides insight into the bank's medium-term interest rate risk exposure and cash flow expectations.

Detailed definition

The amortized cost of available-for-sale debt securities maturing after one year but within five years. This metric help...

Peer comparison

Standard maturity bucket disclosure for financial institutions.

Metric ID: other_available_for_sale_securities_debt_maturities_afte_2b276a

Historical Data

2 periods
 Q4 '25Q1 '26
Value$26.24M$100.73M
QoQ Change—+283.9%
Range$26.24M – $100.73M

Frequently Asked Questions

What is Veradermics 's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five?
Veradermics (MANE) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five of $100.73M in Q1 2026.
What does debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year one through five mean?
The value of investment securities that will mature between one and five years from now.